We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Microbix Biosystems (MBX) Com NPV

Sell:0.37 CAD Buy:0.37 CAD Change: 0.005 CAD (1.33%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:0.37 CAD
Buy:0.37 CAD
Change: 0.005 CAD (1.33%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:0.37 CAD
Buy:0.37 CAD
Change: 0.005 CAD (1.33%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Microbix Biosystems Inc. is a Canada-based life science company, which develops and commercializes biological and technological solutions for human health and wellbeing. The Company manufactures a wide range of critical biological materials for the global diagnostics industry, mainly antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. It operates through two segments: the development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and the development and commercialization of products or technologies such as Kinlytic. Its Kinlyti urokinase is a biologic thrombolytic drug used to treat blood clots.

Contact details

Address:
265 Watline Avenue
MISSISSAUGA
L4Z 1P3
Canada
Telephone:
+1 (905) 3618910
Website:
https://microbix.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
MBX
ISIN:
CA59501P1045
Market cap:
51.54 million CAD
Shares in issue:
137.44 million
Sector:
Biotechnology
Exchange:
Toronto Stock Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • Cameron Groome
    President, Chief Executive Officer, Director
  • James Currie
    Chief Financial Officer
  • Kenneth Hughes
    Chief Operating Officer
  • Phillip Casselli
    Senior Vice President - Sales and Business Development
  • Mark Luscher
    Senior Vice President - Scientific Affairs

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.